MedTrace Logo

Pharmacist Mobile App Intervention in Pediatric Inpatient

NCT07254741 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2025-11-28

No results posted yet for this study

Summary

The goal of this study is to learn whether a clinical pharmacist-led medication review, supported by medical mobile applications, can improve the safety and quality of care for hospitalized children. The study compares usual care with enhanced pharmacist involvement to understand whether this approach reduces medication-related problems and supports better clinical outcomes.

The main questions this study aims to answer are:

Does the pharmacist-led review help identify and prevent medication issues in pediatric inpatients?

Can this intervention improve the overall quality of care during hospitalization?

Does the use of mobile medical applications assist pharmacists in making safer medication decisions?

Participants will:

Receive either routine care or routine care plus daily medication review by a clinical pharmacist

Have their medications assessed regularly to identify potential problems

Be followed during their hospital stay to observe clinical outcomes

Conditions

  • Medication Safety in Pediatric Inpatients

Interventions

BEHAVIORAL

Pharmacist-Led Medication Review

Daily medication review conducted by a clinical pharmacist using mobile medical applications to identify potential medication-related problems and support safer prescribing decisions for hospitalized pediatric patients.

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-12
Primary Completion
2024-09-12
Completion
2024-09-12

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07254741 on ClinicalTrials.gov